Ofev (nintedanib) Disease area(s): Respiratory Manufacturer(s): Boehringer Ingelheim 2024 Sales (USD): $4.07 billion Why it sold so well: In 2024, Boehringer Ingelheims Ofev achieved significant commercial success, with global sales reaching 3.77 billion ($4.07 billion), marking a 7.3% increase at constant exchange rates compared to the previous year
Consumers using GLP-1 medications are seeking more products with protein, fiber and healthy fats while reducing purchases of products high in carbohydrates and sugar, creating potential implications across grocery aisles, pharmacies, product portfolios, merchandising strategies and shopper engagement
They do need to create a login account page so that you can monitor your purchases if necessary
Getting Ozempic covered by insurance usually requires prior authorization
Moderate-Quality Evidence), SGLT2i to reduce the risk of hospitalization for HF or the composite of significant decline in eGFR, progression to end-stage kidney disease or kidney death (Strong Recommendation
If you want to learn more, why not check out these articles below: What Can a Bariatric Patient Take for Constipation